Regeneron social following shoots up and stock surges as pharma company may have Coronavirus treatment Regeneron shares are on the verge of hitting multi-year highs as the New York pharmaceutical company looks to quickly develop a Coronavirus treatment. Jon Marino 3.18.20 1:11 PM Innovation